<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<circle cx="1200" cy="1200" r="1045" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1041" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1040" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1002" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1001" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="990" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="986" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="975" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="974" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="969" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="968" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="948" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="946" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="939" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="939" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="913" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="913" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="795" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="795" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="140" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 mutations 2020 timemap</text>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 252,851 GISAID genomes</text>
<line x1="1200" y1="82.9384615384615" x2="1200" y2="132.938461538462" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="72.9384615384615" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>	<title>orf1ab gene (266-21555)</title>
	<line x1="1208" y1="1060" x2="1208" y2="405" style="stroke:grey;stroke-width:8" />
</g><g>	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="405" x2="1208" y2="287" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF3a gene (25393-26220)</title>
	<line x1="1208" y1="287" x2="1208" y2="261" style="stroke:grey;stroke-width:8" />
</g><g>	<title>E gene (26245-26472)</title>
	<line x1="1208" y1="261" x2="1208" y2="254" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>M gene (26523-27191)</title>
	<line x1="1208" y1="252" x2="1208" y2="232" style="stroke:grey;stroke-width:8" />
</g><g>	<title>ORF6 gene (27202-27387)</title>
	<line x1="1208" y1="231" x2="1208" y2="226" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF7a gene (27394-27759)</title>
	<line x1="1208" y1="225" x2="1208" y2="214" style="stroke:grey;stroke-width:8" />
</g><g>	<title>ORF8 gene (27894-28259)</title>
	<line x1="1208" y1="210" x2="1208" y2="199" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>N gene (28274-29533)</title>
	<line x1="1208" y1="198" x2="1208" y2="160" style="stroke:grey;stroke-width:8" />
</g><g>	<title>ORF10 gene (29558-29674)</title>
	<line x1="1208" y1="159" x2="1208" y2="155" style="stroke:gainsboro;stroke-width:8" />
</g><line x1="1200" y1="147.938461538462" x2="1200" y2="1068" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="147.938461538462" x2="1210" y2="147.938461538462" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="147.938461538462" x2="1215" y2="122.938461538462" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1068" x2="1210" y2="1068" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1068" x2="1215" y2="1093" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="122.938461538462" fill="white">29.9 kb</text>
<text font-size="2.0em" x="1215" y="1113" fill="white">1</text>
<text font-size="2.5em" x="75" y="175" fill="white">Continents</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">Europe</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">North America</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Asia</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">Oceania</text>
<circle cx="60" cy="325" r="8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="335" fill="white">Africa</text>
<circle cx="60" cy="355" r="8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="365" fill="white">South America</text>
<circle cx="60" cy="410" r="1.20411998265592" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="101" cy="410" r="4" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="142" cy="410" r="8" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="183" cy="410" r="12" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="224" cy="410" r="16" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="455" fill="white">2      10        100        1k        10k</text>
<text font-size="2.0em" x="50" y="485" fill="white">genome samples</text>
<g>
	<title>2020-02-08  ATGA1605A  Europe=4 [80.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1314.32331042333" cy="1058.82246903256" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-02-27  ATGA1605A  Europe=2 [4.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1354.05772183715" cy="1103.73405119899" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-02-29  ATGA1605A  Europe=2 [3.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1357.32350719826" cy="1109.16923076923" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-01  ATGA1605A  Europe=5 [5.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1358.88476156772" cy="1111.9287385251" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-02  ATGA1605A  Europe=12 [8.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1360.39761809966" cy="1114.71507364037" r="4.3167249841905" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-02  TGT14865T  Asia=2 [4.8%]  orf1ab polyprotein, V4868*</title>
	<circle cx="1720.64023598611" cy="923.170676023729" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-03  ATGA1605A  Europe=7 [3.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1361.86161596333" cy="1117.52738737039" r="3.38039216005703" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-03  TGT14865T  Asia=2 [7.7%]  orf1ab polyprotein, V4868*</title>
	<circle cx="1725.39227783218" cy="932.299263476656" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-03  ATTA21993A  Europe=2 [1.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1920.81057027571" cy="832.728670179933" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-04  ATGA1605A  Europe=11 [5.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1363.27630921078" cy="1120.36482305715" r="4.1655707406329" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-05  ATGA1605A  Europe=18 [7.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1364.64126691275" cy="1123.22651639024" r="5.02109002041322" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-05  ATGA1605A  Europe=18 [7.5%] Asia=2 [9.1%]  orf1ab polyprotein, D448N</title>
	<circle cx="1364.64126691275" cy="1123.22651639024" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-05  ATTA21993A  Europe=3 [1.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1933.18905651593" cy="858.108328071185" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-06  ATGA1605A  Europe=14 [6.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1365.95607328991" cy="1126.11159567017" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-07  ATGA1605A  Europe=5 [2.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1367.22032783948" cy="1129.01918207383" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-07  ATGA1605A  Europe=5 [2.7%] North America=2 [2.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1367.22032783948" cy="1129.01918207383" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-08  ATGA1605A  Europe=14 [7.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1368.4336454573" cy="1131.94838992223" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-08  TGTT11070T  Oceania=2 [25.0%]  orf1ab polyprotein, L3602F</title>
	<circle cx="1638.45811264114" cy="1022.8514235628" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-08  A11085ATTT  Oceania=3 [37.5%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1638.88604365094" cy="1022.67852821199" r="1.90848501887865" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-08  ATTA21993A  Europe=3 [1.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1950.07747397754" cy="896.949029104887" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-09  ATGA1605A  Europe=19 [3.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1369.59565655506" cy="1134.89832695029" r="5.11501440381132" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-10  TATG517T  Asia=2 [4.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1339.24798959092" cy="1149.31787660749" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-10  ATGA1605A  Europe=25 [6.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1370.70600717292" cy="1137.86809457862" r="5.59176003468815" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-10  ATGA1605A  North America=2 [1.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1370.70600717292" cy="1137.86809457862" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-10  ATGA1605A  North America=2 [1.4%] South America=2 [11.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1370.70600717292" cy="1137.86809457862" r="1.20411998265592" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-11  ATGA1605A  Europe=34 [7.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1371.76435908733" cy="1140.85678818723" r="6.12591566816902" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-12  ATGA1605A  Europe=19 [4.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1372.77038991405" cy="1143.86349739109" r="5.11501440381132" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-12  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1650.18625989799" cy="1053.72561718572" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-13  ATGA1605A  Europe=14 [3.1%]  orf1ab polyprotein, D448N</title>
	<circle cx="1373.72379320633" cy="1146.88730631744" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-14  AGTT668A  North America=2 [0.4%]  orf1ab polyprotein, S135N</title>
	<circle cx="1346.91036442233" cy="1157.87413088175" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-14  ATGA1605A  Europe=15 [4.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1374.6242785483" cy="1149.92729388481" r="4.70436503622272" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-14  ATGA1605A  Europe=15 [4.4%] North America=2 [0.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1374.6242785483" cy="1149.92729388481" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-14  A11085ATTT  North America=3 [0.6%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1655.01692093277" cy="1069.52599748035" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-15  ATGA1605A  Europe=5 [1.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1375.4715716434" cy="1152.98253408353" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-15  ATGA1605A  Europe=5 [1.4%] North America=4 [0.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1375.4715716434" cy="1152.98253408353" r="2.40823996531185" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-15  A11085ATTT  North America=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1657.22470497326" cy="1077.48700954286" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-16  ATGA1605A  Europe=21 [3.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1376.26541439795" cy="1156.05209625783" r="5.28887717893568" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-16  ATGA1605A  Europe=21 [3.0%] North America=3 [0.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1376.26541439795" cy="1156.05209625783" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-16  ATGA1605A  Europe=21 [3.0%] North America=3 [0.4%] Oceania=2 [4.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1376.26541439795" cy="1156.05209625783" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-16  TGT14865T  Asia=2 [2.3%]  orf1ab polyprotein, V4868*</title>
	<circle cx="1772.14607071856" cy="1057.34796285317" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-17  ATGA1605A  Europe=25 [3.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1377.00556499975" cy="1159.13504538935" r="5.59176003468815" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-17  ATGA1605A  Europe=25 [3.8%] North America=3 [0.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1377.00556499975" cy="1159.13504538935" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-18  ATGA1605A  Europe=23 [3.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1377.69179799177" cy="1162.23044238191" r="5.44691134407037" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-18  TGTT26157T  Europe=2 [0.3%]  ORF3a protein, V256N</title>
	<circle cx="2116.62964085996" cy="1005.16435521398" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-19  ATGA1605A  Europe=29 [4.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1378.32390434077" cy="1165.3373443476" r="5.84959199159582" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-19  A11085ATTT  Europe=2 [0.3%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1664.65700277412" cy="1109.67982815776" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-20  ATGA1605A  Europe=25 [3.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1378.90169150105" cy="1168.45480489398" r="5.59176003468815" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-21  ATGA1605A  Europe=31 [6.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1379.42498347304" cy="1171.58187441238" r="5.96544677533709" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-21  ATGA1605A  Europe=31 [6.0%] Oceania=2 [1.3%]  orf1ab polyprotein, D448N</title>
	<circle cx="1379.42498347304" cy="1171.58187441238" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-21  TT11083T  Europe=2 [0.4%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1667.46529400106" cy="1125.9607710385" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-22  ATGA1605A  Europe=31 [5.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1379.89362085693" cy="1174.71760036713" r="5.96544677533709" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-23  ATGA1605A  Europe=57 [6.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.30746090124" cy="1177.86102758572" r="7.02349942268996" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-23  A11085ATTT  Europe=4 [0.5%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1669.82553836462" cy="1142.31267757093" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-23  ATTA21993A  Europe=3 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="2002.95456673703" cy="1101.40957609821" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-23  TATT27699T  Asia=2 [2.2%]  ORF7a protein, I103V</title>
	<circle cx="2177.21513108366" cy="1080.01306922222" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-24  AGTT668A  North America=2 [0.4%]  orf1ab polyprotein, S135N</title>
	<circle cx="1351.99354628598" cy="1184.02483455229" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-24  ATGA1605A  Europe=40 [4.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.66637754629" cy="1181.01119854978" r="6.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-24  ATGA1605A  Europe=40 [4.6%] Oceania=2 [1.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.66637754629" cy="1181.01119854978" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-24  A11085ATTT  Europe=2 [0.2%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1670.76076425679" cy="1150.52104987971" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-24  TCAT27296T  Oceania=2 [1.7%]  ORF6 protein, I33N</title>
	<circle cx="2166.82828566648" cy="1098.3822524018" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-25  ATGA1605A  Europe=42 [5.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.97026146257" cy="1184.1671536867" r="6.4929971615916" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-26  ATGA1605A  Europe=42 [5.1%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.21902008412" cy="1187.32793166199" r="6.4929971615916" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-26  A11085ATTT  Europe=2 [0.2%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1672.2007799753" cy="1166.98050485909" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-27  ATGA1605A  Europe=48 [4.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.41257763665" cy="1190.49256967205" r="6.72496494950235" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-27  ATGA1605A  Europe=48 [4.8%] Oceania=2 [1.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.41257763665" cy="1190.49256967205" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-27  A11085ATTT  Europe=3 [0.3%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1672.7051311589" cy="1175.22657382026" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-27  A11085ATTT  Europe=3 [0.3%] Oceania=2 [1.6%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1672.7051311589" cy="1175.22657382026" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-28  ATGA1605A  Europe=26 [3.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.55087516064" cy="1193.66010373749" r="5.65989339188327" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-28  A11085ATTT  Europe=3 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1673.06549178036" cy="1183.48018900704" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-29  TTAT516T  Europe=2 [0.3%]  orf1ab polyprotein, M85V</title>
	<circle cx="1348.13128160548" cy="1197.41435886168" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-29  ATGA1605A  Europe=21 [3.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.63387052933" cy="1196.82956899675" r="5.28887717893568" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-29  A11085ATTT  Oceania=2 [3.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1673.28175207034" cy="1191.73883628827" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-30  ATGA1605A  Europe=47 [4.3%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.66153846154" cy="1200" r="6.68839143174287" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-30  ATGA1605A  Europe=47 [4.3%] Oceania=2 [2.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.66153846154" cy="1200" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-30  A11085ATTT  Europe=2 [0.2%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1673.35384615385" cy="1200" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-30  A11085ATTT  Europe=2 [0.2%] Asia=2 [1.8%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1673.35384615385" cy="1200" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-31  ATGA1605A  Europe=24 [2.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.63387052933" cy="1203.17043100325" r="5.52084496684642" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-03-31  GTTA26158G  North America=2 [0.5%]  ORF3a protein, V256D</title>
	<circle cx="2136.99573081164" cy="1216.35532131878" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-01  TTAT516T  North America=2 [0.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1348.06359483375" cy="1205.17049466531" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-01  ATGA1605A  Europe=21 [2.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.55087516064" cy="1206.33989626251" r="5.28887717893568" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-02  ATGA1605A  Europe=19 [2.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.41257763665" cy="1209.50743032795" r="5.11501440381132" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-03  ATGA1605A  Europe=12 [1.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1381.21902008412" cy="1212.67206833801" r="4.3167249841905" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-03  ATTA9859A  Europe=2 [0.3%]  orf1ab polyprotein, L3199P</title>
	<circle cx="1634.56959457165" cy="1230.38806631598" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-03  ATTA21993A  Europe=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="2007.01396952096" cy="1256.43191408248" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-04  ATGA1605A  Europe=8 [1.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.97026146257" cy="1215.8328463133" r="3.61235994796777" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-04  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1671.5525918598" cy="1241.255506044" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-04  ATTA21993A  Europe=2 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="2005.90618468394" cy="1270.50765502527" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-05  ATGA1605A  Europe=12 [2.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.66637754629" cy="1218.98880145022" r="4.3167249841905" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-05  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1670.76076425679" cy="1249.47895012029" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-06  ATGA1605A  Europe=19 [2.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1380.30746090124" cy="1222.13897241428" r="5.11501440381132" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-07  ATGA1605A  Europe=15 [2.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1379.89362085693" cy="1225.28239963287" r="4.70436503622272" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-07  A11085ATTT  Europe=4 [0.5%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1668.74719906216" cy="1265.8781226206" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-08  TTAT516T  Europe=3 [0.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1346.32982646048" cy="1223.17636766673" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-08  ATGA1605A  Europe=20 [2.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1379.42498347304" cy="1228.41812558762" r="5.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-09  ATGA1605A  Europe=14 [2.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1378.90169150105" cy="1231.54519510602" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-10  ATGA1605A  Europe=10 [1.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1378.32390434077" cy="1234.6626556524" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-11  ATGA1605A  Europe=6 [1.1%]  orf1ab polyprotein, D448N</title>
	<circle cx="1377.69179799177" cy="1237.76955761809" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-12  ATGA1605A  Europe=9 [2.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1377.00556499975" cy="1240.86495461065" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-12  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1661.22181774326" cy="1306.48144677003" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-13  ATGA1605A  Europe=4 [0.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1376.26541439795" cy="1243.94790374217" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-13  A11085ATTT  Europe=2 [0.3%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1659.29321393938" cy="1314.51465975093" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-14  ATGA1605A  Europe=7 [1.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1375.4715716434" cy="1247.01746591647" r="3.38039216005703" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-14  ATTA21993A  Europe=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1981.41913307053" cy="1409.38062565648" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-15  ATGA1605A  Europe=5 [1.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1374.6242785483" cy="1250.07270611519" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-15  ATTA9859A  Europe=2 [0.4%]  orf1ab polyprotein, L3199P</title>
	<circle cx="1618.75517203368" cy="1320.07611334329" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-15  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1655.01692093277" cy="1330.47400251965" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-15  TT27206T  Europe=2 [0.4%]  ORF6 protein, H3I</title>
	<circle cx="2131.83229940113" cy="1467.19861215429" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-16  ATGA1605A  Europe=10 [1.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1373.72379320633" cy="1253.11269368256" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-16  TT27206T  Europe=2 [0.4%]  ORF6 protein, H3I</title>
	<circle cx="2127.02711804971" cy="1483.42063253199" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-17  ATGA1605A  Europe=14 [2.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1372.77038991405" cy="1256.13650260891" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-18  ATGA1605A  Europe=4 [1.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1371.76435908733" cy="1259.14321181277" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-19  A11085ATTT  Europe=2 [0.6%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1644.8071162514" cy="1361.8965503053" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-20  ATGA1605A  Europe=11 [1.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1369.59565655506" cy="1265.10167304971" r="4.1655707406329" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-21  AGTT668A  North America=2 [0.6%]  orf1ab polyprotein, S135N</title>
	<circle cx="1341.70222171179" cy="1257.25141383067" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-21  ATGA1605A  Europe=18 [3.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1368.4336454573" cy="1268.05161007777" r="5.02109002041322" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-22  ATGA1605A  Europe=10 [2.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1367.22032783948" cy="1270.98081792617" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-23  ATGA1605A  Europe=5 [1.1%]  orf1ab polyprotein, D448N</title>
	<circle cx="1365.95607328991" cy="1273.88840432983" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-23  TATT27699T  Africa=2 [4.8%]  ORF7a protein, I103V</title>
	<circle cx="2099.4346939584" cy="1600.45412631198" r="1.20411998265592" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-24  ATGA1605A  Europe=10 [2.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1364.64126691275" cy="1276.77348360976" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-25  ATGA1605A  Europe=4 [1.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1363.27630921078" cy="1279.63517694285" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-26  ATGA1605A  Europe=5 [2.3%]  orf1ab polyprotein, D448N</title>
	<circle cx="1361.86161596333" cy="1282.47261262961" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-26  ATTG3332A  Asia=20 [20.2%]  orf1ab polyprotein, I1023K</title>
	<circle cx="1409.20833187943" cy="1306.59696933885" r="5.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-27  ATGA1605A  Europe=10 [2.3%]  orf1ab polyprotein, D448N</title>
	<circle cx="1360.39761809966" cy="1285.28492635963" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-27  ATTA21993A  Europe=2 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1914.29101881375" cy="1579.79527165436" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-28  ATGA1605A  Europe=5 [1.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1358.88476156772" cy="1288.0712614749" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-29  ATGA1605A  Europe=4 [1.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1357.32350719826" cy="1290.83076923077" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-29  A11085ATTT  Europe=2 [0.6%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1609.9364557483" cy="1436.67692307692" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-04-30  ATGA1605A  Europe=9 [2.5%]  orf1ab polyprotein, D448N</title>
	<circle cx="1355.71433056447" cy="1293.56260905443" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-01  ATGA1605A  Europe=4 [1.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1354.05772183715" cy="1296.26594880101" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-02  ATGA1605A  Europe=2 [0.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1352.35418563538" cy="1298.93996500704" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-03  ATGA1605A  Europe=2 [1.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1350.60424087277" cy="1301.58384314127" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-05  ATGA1605A  Europe=11 [3.6%]  orf1ab polyprotein, D448N</title>
	<circle cx="1346.96727183968" cy="1306.77797321645" r="4.1655707406329" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-05  TGTT26157T  North America=5 [2.6%]  ORF3a protein, V256N</title>
	<circle cx="1958.13604863641" cy="1750.81808134829" r="2.79588001734407" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-05  TGTT26157T  North America=5 [2.6%] South America=2 [6.9%]  ORF3a protein, V256N</title>
	<circle cx="1958.13604863641" cy="1750.81808134829" r="1.20411998265592" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-06  ATGA1605A  Europe=2 [0.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1345.08135542521" cy="1309.32664297507" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-06  A11085ATTT  Europe=2 [0.7%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1578.03719035592" cy="1484.87145588219" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-06  ATTA21993A  Europe=2 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1846.08384092811" cy="1686.85909503734" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-07  ATGA1605A  Europe=2 [0.9%]  orf1ab polyprotein, D448N</title>
	<circle cx="1343.15124582443" cy="1311.84201077916" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-07  AGTT11282A  Europe=2 [0.9%]  orf1ab polyprotein, S3673M</title>
	<circle cx="1577.78447852143" cy="1495.15758298613" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-08  ATGA1605A  Europe=3 [1.2%]  orf1ab polyprotein, D448N</title>
	<circle cx="1341.17753096744" cy="1314.32331042333" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-08  AGTT11282A  Europe=2 [0.8%]  orf1ab polyprotein, S3673M</title>
	<circle cx="1572.57573001419" cy="1501.70587732146" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-09  TATG517T  Europe=2 [1.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1313.51600117111" cy="1295.2512347154" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-09  A11085ATTT  Europe=2 [1.2%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1562.61008347515" cy="1504.26598730516" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-12  ATGA1605A  Europe=2 [0.8%]  orf1ab polyprotein, D448N</title>
	<circle cx="1332.85883859568" cy="1323.8928713172" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-15  ATGA1605A  Europe=3 [2.0%]  orf1ab polyprotein, D448N</title>
	<circle cx="1326.19270828277" cy="1330.67637480614" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-18  ATTA21993A  Europe=2 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1730.74166123749" cy="1810.5484394836" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-18  TGTT26157T  North America=2 [0.9%]  ORF3a protein, V256N</title>
	<circle cx="1814.79796267492" cy="1907.24415308507" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-18  AATT27578A  Europe=2 [0.7%]  ORF7a protein, Q62H</title>
	<circle cx="1843.48288206555" cy="1940.24237811573" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-18  AATT27578A  Europe=2 [0.7%] Asia=2 [0.7%]  ORF7a protein, Q62H</title>
	<circle cx="1843.48288206555" cy="1940.24237811573" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-19  TATG517T  North America=2 [0.9%]  orf1ab polyprotein, M85V</title>
	<circle cx="1295.2512347154" cy="1313.51600117111" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-20  TGTT26157T  North America=2 [1.1%]  ORF3a protein, V256N</title>
	<circle cx="1789.74097937889" cy="1928.26945852718" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-22  A11085ATTT  Europe=2 [1.1%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1484.87145588219" cy="1578.03719035592" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-23  GTTA26158G  Asia=2 [2.7%]  ORF3a protein, V256D</title>
	<circle cx="1750.83616704836" cy="1958.16094146701" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-24  ATTA21993A  Europe=2 [2.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1664.01451275513" cy="1862.68140149065" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-27  ATGA1605A  Europe=2 [1.4%]  orf1ab polyprotein, D448N</title>
	<circle cx="1296.26594880101" cy="1354.05772183715" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-05-28  TATG517T  North America=3 [2.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1276.32071903898" cy="1327.01900677481" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-07  T25704TCCC  Europe=4 [1.9%]  ORF3a protein, F105P</title>
	<circle cx="1530.83426431408" cy="2061.85272419063" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-08  ATTA21993A  Europe=4 [1.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1476.68903410211" cy="1960.19687340625" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-09  A11085ATTT  Europe=2 [0.7%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1354.1089380975" cy="1647.56485436984" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-09  ATTA21993A  Europe=2 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1463.379628215" cy="1964.90998122022" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-09  ATTA21993A  Europe=2 [0.7%] North America=2 [1.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1463.379628215" cy="1964.90998122022" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-10  TGTT11070T  Europe=2 [0.7%]  orf1ab polyprotein, L3602F</title>
	<circle cx="1346.13175958611" cy="1649.74731073662" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-10  A11085ATTT  Europe=3 [1.0%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1346.27438281428" cy="1650.18625989799" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-10  ATTA21993A  Europe=2 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1449.98999434173" cy="1969.39009004407" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-11  G11083GTTT  Europe=2 [0.6%]  orf1ab polyprotein, Y3607F</title>
	<circle cx="1338.37727883216" cy="1652.61168480687" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-11  ATTA21993A  Europe=4 [1.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1436.52421109447" cy="1973.63583519323" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-11  ATTA21993A  Europe=4 [1.1%] Africa=2 [5.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1436.52421109447" cy="1973.63583519323" r="1.20411998265592" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-11  TGTT26157T  Europe=2 [0.6%]  ORF3a protein, V256N</title>
	<circle cx="1473.98377350879" cy="2096.16054300339" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-12  T25704TCCC  Europe=4 [1.0%]  ORF3a protein, F105P</title>
	<circle cx="1454.45992574084" cy="2087.4072204073" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-12  TGTT26157T  Europe=2 [0.5%]  ORF3a protein, V256N</title>
	<circle cx="1458.30188642346" cy="2100.80572958454" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-13  TATG517T  Europe=2 [0.7%]  orf1ab polyprotein, M85V</title>
	<circle cx="1238.35300065273" cy="1343.13534705871" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-13  ATGA1605A  Africa=2 [6.1%]  orf1ab polyprotein, D448N</title>
	<circle cx="1247.01746591647" cy="1375.4715716434" r="1.20411998265592" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-14  TGTT26157T  Europe=4 [1.3%]  ORF3a protein, V256N</title>
	<circle cx="1426.70686930411" cy="2109.27158890652" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-15  ATTA21993A  Europe=2 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1381.98194217874" cy="1988.25039210257" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-16  T25704TCCC  Europe=3 [0.9%]  ORF3a protein, F105P</title>
	<circle cx="1391.93767568016" cy="2102.9957681482" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-17  AC5627A  Asia=3 [2.9%]  orf1ab polyprotein, T1788S</title>
	<circle cx="1258.276002711" cy="1499.80404378159" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-17  AGCA6502A  Europe=2 [0.7%]  orf1ab polyprotein, A2080N</title>
	<circle cx="1263.41316797114" cy="1526.23246795133" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-17  G11083GTTT  Europe=2 [0.7%]  orf1ab polyprotein, Y3607F</title>
	<circle cx="1290.30842975022" cy="1664.59659494745" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-17  TGTT26157T  Europe=2 [0.7%]  ORF3a protein, V256N</title>
	<circle cx="1378.80857732886" cy="2119.89038458714" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-17  TGTTA26157T  Asia=2 [1.9%]  ORF3a protein, V256I</title>
	<circle cx="1378.80857732886" cy="2119.89038458714" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-17  GTTA26158G  Asia=2 [1.9%]  ORF3a protein, V256D</title>
	<circle cx="1378.81444837487" cy="2119.92058850048" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-18  TGTT26157T  Europe=2 [1.0%]  ORF3a protein, V256N</title>
	<circle cx="1362.72704304689" cy="2122.87092079199" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-19  G11083GTTT  Europe=2 [0.7%]  orf1ab polyprotein, Y3607F</title>
	<circle cx="1274.0392289615" cy="1667.46529400106" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-19  A11085ATTT  Oceania=2 [9.5%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1274.04885569781" cy="1667.52607482202" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-19  TGTT26157T  Europe=3 [1.1%]  ORF3a protein, V256N</title>
	<circle cx="1346.59594053124" cy="2125.57034157432" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-20  ATTA9859A  Europe=2 [1.4%]  orf1ab polyprotein, L3199P</title>
	<circle cx="1260.62808502746" cy="1631.39124053056" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-06-23  ATTA21993A  Europe=2 [0.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1270.50765502527" cy="2005.90618468394" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-01  ATGA1605A  North America=3 [0.7%]  orf1ab polyprotein, D448N</title>
	<circle cx="1190.49256967205" cy="1381.41257763665" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-01  T25704TCCC  Europe=4 [2.1%]  ORF3a protein, F105P</title>
	<circle cx="1151.68505553363" cy="2121.90405942281" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-02  G11083GTTT  Europe=3 [1.3%]  orf1ab polyprotein, Y3607F</title>
	<circle cx="1166.98479756517" cy="1672.13939141836" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-02  A23125ATCC  North America=5 [1.1%]  surface glycoprotein, A522S</title>
	<circle cx="1141.13841427819" cy="2041.75989274847" r="2.79588001734407" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-03  A23125ATCC  North America=2 [0.7%]  surface glycoprotein, A522S</title>
	<circle cx="1126.45664341195" cy="2040.60441232209" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-04  G11083GTTT  Europe=2 [1.5%]  orf1ab polyprotein, Y3607F</title>
	<circle cx="1150.52748240052" cy="1670.69956290938" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-05  ATTA22190A  Oceania=2 [2.2%]  surface glycoprotein, I210N</title>
	<circle cx="1100.67086038588" cy="2008.97092341006" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-06  ATTA22190A  Europe=3 [2.4%]  surface glycoprotein, I210N</title>
	<circle cx="1086.56749934366" cy="2007.11418070448" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-06  A23125ATCC  North America=2 [0.5%]  surface glycoprotein, A522S</title>
	<circle cx="1082.56359628527" cy="2035.6034312975" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-06  TGTT26157T  Asia=3 [3.7%]  ORF3a protein, V256N</title>
	<circle cx="1069.57981652801" cy="2127.98782466441" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-08  AATA6509A  Europe=2 [2.9%]  orf1ab polyprotein, N2082S</title>
	<circle cx="1142.25263063926" cy="1527.50160598634" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-09  ATTA21993A  North America=2 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1045.63845826338" cy="1994.12128945249" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-09  A23125ATCC  North America=2 [0.5%]  surface glycoprotein, A522S</title>
	<circle cx="1038.99243417827" cy="2028.31211934981" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-09  TGTTA26157T  Asia=3 [10.3%]  ORF3a protein, V256I</title>
	<circle cx="1021.19142267114" cy="2119.89038458714" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-13  ATTA21993A  North America=2 [1.6%]  surface glycoprotein, Y145H</title>
	<circle cx="990.619374343524" cy="1981.41913307053" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-14  AGCA6502A  Europe=2 [1.6%]  orf1ab polyprotein, A2080N</title>
	<circle cx="1108.39510522525" cy="1519.46423316399" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-16  ATTA21993A  North America=2 [1.4%]  surface glycoprotein, Y145H</title>
	<circle cx="950.010005658273" cy="1969.39009004407" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-21  ATTA21993A  North America=2 [1.5%]  surface glycoprotein, Y145H</title>
	<circle cx="883.904528300308" cy="1944.67426482989" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-22  TTAT516T  North America=7 [6.0%]  orf1ab polyprotein, M85V</title>
	<circle cx="1139.74040195662" cy="1335.34527318613" r="3.38039216005703" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-22  ATTA21993A  North America=2 [1.7%]  surface glycoprotein, Y145H</title>
	<circle cx="870.956313238494" cy="1939.04422068736" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-24  TTAT516T  North America=2 [1.5%]  orf1ab polyprotein, M85V</title>
	<circle cx="1135.05362856033" cy="1333.1597948594" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-28  ATTA9859A  North America=2 [1.3%]  orf1ab polyprotein, L3199P</title>
	<circle cx="982.184615384615" cy="1577.267312824" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-28  TATT20424T  Europe=3 [3.6%]  orf1ab polyprotein, I6721P</title>
	<circle cx="819.646153846154" cy="1858.7921863927" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-29  TTAT516T  Oceania=2 [0.7%]  orf1ab polyprotein, M85V</title>
	<circle cx="1123.6951282864" cy="1326.99263239633" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-29  TGTT26157T  North America=2 [1.6%]  ORF3a protein, V256N</title>
	<circle cx="717.353858170443" cy="2003.25807108257" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-30  TACA6523T  North America=4 [3.2%]  orf1ab polyprotein, T2087E</title>
	<circle cx="1023.54503761441" cy="1482.3869691263" r="2.40823996531185" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-07-30  T25704TCCC  Oceania=7 [3.4%]  ORF3a protein, F105P</title>
	<circle cx="710.794840468036" cy="1982.89190858404" r="3.38039216005703" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-02  T25704TCCC  Oceania=4 [2.1%]  ORF3a protein, F105P</title>
	<circle cx="670.491882466448" cy="1956.21596260931" r="2.40823996531185" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-03  TTTT21981T  North America=6 [2.7%]  surface glycoprotein, F140L</title>
	<circle cx="724.707802146271" cy="1854.18358806688" r="3.11260500153457" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-04  T25704TCCC  Oceania=2 [1.0%]  ORF3a protein, F105P</title>
	<circle cx="644.422888011357" cy="1937.27572947535" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-04  TGTT26157T  North America=2 [1.3%]  ORF3a protein, V256N</title>
	<circle cx="636.034512457883" cy="1948.4074798154" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-06  TACA6523T  North America=5 [2.5%]  orf1ab polyprotein, T2087E</title>
	<circle cx="990.445991632574" cy="1458.77764907346" r="2.79588001734407" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-06  T25704TCCC  Oceania=6 [2.9%]  ORF3a protein, F105P</title>
	<circle cx="619.03077868713" cy="1917.43723943365" r="3.11260500153457" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-07  T25704TCCC  Oceania=2 [1.8%]  ORF3a protein, F105P</title>
	<circle cx="606.598256817685" cy="1907.18865928919" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-11  TGTT26157T  North America=2 [0.9%]  ORF3a protein, V256N</title>
	<circle cx="549.030297516947" cy="1874.09886028043" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-12  T25704TCCC  Oceania=2 [1.6%]  ORF3a protein, F105P</title>
	<circle cx="547.220776740308" cy="1852.77922325969" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-13  T25704TCCC  Oceania=2 [1.5%]  ORF3a protein, F105P</title>
	<circle cx="535.927629859675" cy="1841.28723350404" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-13  TGTT26157T  Europe=2 [0.8%]  ORF3a protein, V256N</title>
	<circle cx="525.90113971957" cy="1850.96970248305" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-14  ATTA9859A  Europe=2 [0.8%]  orf1ab polyprotein, L3199P</title>
	<circle cx="881.39982438387" cy="1497.09947020815" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-14  T25704TCCC  Oceania=3 [2.6%]  ORF3a protein, F105P</title>
	<circle cx="524.836765856001" cy="1829.59990144477" r="1.90848501887865" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-16  T25704TCCC  Oceania=2 [2.3%]  ORF3a protein, F105P</title>
	<circle cx="503.275337371574" cy="1805.65350913237" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-18  A11085ATTT  Europe=2 [0.6%]  orf1ab polyprotein, E3608F</title>
	<circle cx="832.134970121414" cy="1497.89122756648" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-18  A21547ACTCTA  North America=3 [1.3%]  orf1ab polyprotein, N7095T</title>
	<circle cx="581.965707082558" cy="1700.47430237151" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-18  T25704TCCC  Oceania=2 [2.2%]  ORF3a protein, F105P</title>
	<circle cx="482.562760566354" cy="1780.96922131287" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-19  AACA12782A  Europe=3 [1.3%]  orf1ab polyprotein, N4173T</title>
	<circle cx="785.845794389033" cy="1523.57272800116" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-19  T25704TCCC  Oceania=2 [2.0%]  ORF3a protein, F105P</title>
	<circle cx="472.532718755001" cy="1768.35973059064" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-20  ATTA9859A  Europe=2 [0.5%]  orf1ab polyprotein, L3199P</title>
	<circle cx="852.08979842309" cy="1462.16914147036" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-20  AACA12782A  Europe=3 [0.8%]  orf1ab polyprotein, N4173T</title>
	<circle cx="780.261749319452" cy="1516.29545878339" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-21  AACA12782A  Europe=3 [1.1%]  orf1ab polyprotein, N4173T</title>
	<circle cx="774.805560587124" cy="1508.92184290485" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-21  T25704TCCC  Oceania=2 [1.8%]  ORF3a protein, F105P</title>
	<circle cx="453.140403623645" cy="1742.62525921634" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-22  T25704TCCC  Oceania=3 [5.1%]  ORF3a protein, F105P</title>
	<circle cx="443.784037390689" cy="1729.50811753355" r="1.90848501887865" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-23  AATT12626A  Europe=2 [2.7%]  orf1ab polyprotein, N4121I</title>
	<circle cx="768.262741061721" cy="1491.21045819207" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-23  T25704TCCC  Oceania=3 [4.8%]  ORF3a protein, F105P</title>
	<circle cx="434.658021865572" cy="1716.2296825487" r="1.90848501887865" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-26  A11085ATTT  Europe=2 [0.5%]  orf1ab polyprotein, E3608F</title>
	<circle cx="794.256561415345" cy="1443.79525367435" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-26  AATT12626A  Europe=2 [0.5%]  orf1ab polyprotein, N4121I</title>
	<circle cx="753.613644172823" cy="1468.21598208777" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-26  T25704TCCC  Oceania=2 [2.8%]  ORF3a protein, F105P</title>
	<circle cx="408.689522370293" cy="1675.46730343158" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-27  A11085ATTT  Europe=2 [0.5%]  orf1ab polyprotein, E3608F</title>
	<circle cx="790.063544251698" cy="1436.67692307692" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-27  AATT12626A  Europe=4 [1.0%]  orf1ab polyprotein, N4121I</title>
	<circle cx="749.000616644565" cy="1460.38461538462" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-28  T25704TCCC  Oceania=3 [5.2%]  ORF3a protein, F105P</title>
	<circle cx="392.577997744514" cy="1647.56132419233" r="1.90848501887865" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-08-28  C28994CGGC  Europe=2 [0.6%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="304.039572006403" cy="1696.63897498035" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-01  TATG517T  Europe=2 [0.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1065.69912915789" cy="1262.62552457056" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-01  AATT12626A  Europe=3 [0.6%]  orf1ab polyprotein, N4121I</title>
	<circle cx="728.02279090476" cy="1420.08658707573" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-02  AATT12626A  Europe=2 [0.6%]  orf1ab polyprotein, N4121I</title>
	<circle cx="724.253634750738" cy="1411.81592874024" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-02  A23125ATCC  North America=2 [1.0%]  surface glycoprotein, A522S</title>
	<circle cx="429.136288295671" cy="1543.21063691418" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-04  T28251TCTG  Europe=3 [1.0%]  ORF8 protein, F120S</title>
	<circle cx="271.389708733879" cy="1575.18291125194" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-07  CATC28253C  Europe=2 [0.3%]  ORF8 protein, I121*</title>
	<circle cx="252.968594679724" cy="1526.08906350429" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-08  TATG517T  Europe=2 [0.6%]  orf1ab polyprotein, M85V</title>
	<circle cx="1059.06805592377" cy="1245.79156445876" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-09  ATTA22190A  Europe=2 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="420.567486747543" cy="1438.29643342771" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-09  T25704TCCC  Oceania=2 [7.4%]  ORF3a protein, F105P</title>
	<circle cx="317.168874056648" cy="1469.90856174758" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-10  AATT12626A  Europe=3 [0.3%]  orf1ab polyprotein, N4121I</title>
	<circle cx="699.404486038276" cy="1343.54345376008" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-10  ATTA22190A  Europe=5 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="416.527351885842" cy="1424.65716671497" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-11  ATTA9859A  Europe=2 [0.6%]  orf1ab polyprotein, L3199P</title>
	<circle cx="779.212989273827" cy="1312.74953970958" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-11  A23125ATCC  North America=2 [1.0%]  surface glycoprotein, A522S</title>
	<circle cx="384.936927379957" cy="1418.39549208897" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-11  T28251TCTG  Europe=2 [0.6%]  ORF8 protein, F120S</title>
	<circle cx="232.588133978179" cy="1459.21722824883" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-12  TATT27699T  South America=2 [100.0%]  ORF7a protein, I103V</title>
	<circle cx="244.691610788328" cy="1438.18513278148" r="1.20411998265592" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-16  ATTA9859A  Europe=2 [0.2%]  orf1ab polyprotein, L3199P</title>
	<circle cx="770.987441010866" cy="1275.64648921257" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-16  ATTA22190A  Europe=4 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="397.336228629527" cy="1341.53127932983" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-21  ATTA9859A  Europe=2 [0.1%]  orf1ab polyprotein, L3199P</title>
	<circle cx="766.026937366679" cy="1237.96772325604" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-21  ATTA22190A  Europe=3 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="388.055342838392" cy="1271.03595291208" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-22  ATTA22190A  Europe=2 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="386.939257620539" cy="1256.85474563102" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-24  ATTA22190A  Europe=2 [0.1%]  surface glycoprotein, I210N</title>
	<circle cx="385.450350248959" cy="1228.44470055854" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-24  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="263.432417891674" cy="1232.70566064825" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-24  AATT27578A  Europe=3 [0.2%]  ORF7a protein, Q62H</title>
	<circle cx="219.766726372686" cy="1234.23050019648" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-24  CATC28253C  Asia=2 [15.4%]  ORF8 protein, I121*</title>
	<circle cx="199.010147657674" cy="1234.95533589723" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-24  C28994CGGC  Europe=2 [0.1%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="176.224036801638" cy="1235.75104442204" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-25  AGTT668A  Europe=2 [0.3%]  orf1ab polyprotein, S135N</title>
	<circle cx="1047.19250763564" cy="1202.66726470074" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-25  ATTA22190A  Europe=6 [0.8%]  surface glycoprotein, I210N</title>
	<circle cx="385.077981630842" cy="1214.22451674207" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-25  C28932CTTTTG  Europe=3 [0.4%]  nucleocapsid phosphoprotein, L221F</title>
	<circle cx="177.663422838707" cy="1217.84495133284" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-25  TTGCTG28934T  Europe=3 [0.4%]  nucleocapsid phosphoprotein, L221S</title>
	<circle cx="177.601893749774" cy="1217.84602532708" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-26  ATTA22190A  Europe=2 [0.8%]  surface glycoprotein, I210N</title>
	<circle cx="384.953846153846" cy="1200" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-26  A23125ATCC  North America=2 [2.7%]  surface glycoprotein, A522S</title>
	<circle cx="356.184615384615" cy="1200" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-27  TATG517T  Europe=2 [0.3%]  orf1ab polyprotein, M85V</title>
	<circle cx="1051.83795385006" cy="1197.41382186456" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-09-30  GGTT28089G  Asia=6 [8.6%]  ORF8 protein, G66A</title>
	<circle cx="205.873708928763" cy="1130.48391779616" r="3.11260500153457" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-01  ATTA22190A  Europe=3 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="388.055342838392" cy="1128.96404708792" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-01  AATG28900A  North America=6 [3.6%]  nucleocapsid phosphoprotein, M210A</title>
	<circle cx="182.379452863143" cy="1110.96973835448" r="3.11260500153457" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-02  GGTT28089G  Asia=3 [10.0%]  ORF8 protein, G66A</title>
	<circle cx="208.905380086534" cy="1095.83175789807" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-03  GGTT28089G  Asia=19 [14.6%]  ORF8 protein, G66A</title>
	<circle cx="210.874315096642" cy="1078.55063710136" r="5.11501440381132" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-04  ATTA22190A  Europe=3 [1.1%]  surface glycoprotein, I210N</title>
	<circle cx="392.885819295524" cy="1086.56749934366" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-05  ATTA21993A  Europe=3 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="400.975327663773" cy="1073.44692446653" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-05  ATTA22190A  Europe=3 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="394.988416799243" cy="1072.49869093998" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-06  ATTA22190A  Europe=2 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="397.336228629527" cy="1058.46872067017" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-06  GGTT28089G  Asia=3 [8.1%]  ORF8 protein, G66A</title>
	<circle cx="218.586046013557" cy="1026.95024066841" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-07  TATG517T  Europe=2 [0.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1054.53795336972" cy="1171.7250424082" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-07  ATTA21993A  Europe=3 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="405.878710547508" cy="1045.63845826338" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-07  ATTA22190A  Europe=3 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="399.928539620149" cy="1044.4818621991" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-07  GGTT28089G  Asia=3 [12.5%]  ORF8 protein, G66A</title>
	<circle cx="221.755654846063" cy="1009.84856177675" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-08  ATTA22190A  Europe=2 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="402.764560128068" cy="1030.54237605933" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-09  TACA6523T  North America=2 [1.2%]  orf1ab polyprotein, T2087E</title>
	<circle cx="875.549758735206" cy="1125.09475968894" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-09  ATTA22190A  Europe=2 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="405.843426273966" cy="1016.6545083534" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-09  GTTA26158G  Europe=2 [0.3%]  ORF3a protein, V256D</title>
	<circle cx="286.880336518033" cy="989.189715010736" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-11  ATTA22190A  Europe=5 [1.2%]  surface glycoprotein, I210N</title>
	<circle cx="412.725870382427" cy="989.050532747056" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-11  ATTA22190A  Europe=5 [1.2%] Oceania=2 [22.2%]  surface glycoprotein, I210N</title>
	<circle cx="412.725870382427" cy="989.050532747056" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-12  ATTA21993A  Europe=2 [0.1%]  surface glycoprotein, Y145H</title>
	<circle cx="422.354076627376" cy="977.013619718753" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-12  ATTA22190A  Europe=15 [0.7%]  surface glycoprotein, I210N</title>
	<circle cx="416.527351885842" cy="975.342833285031" r="4.70436503622272" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-12  TGTTA26157T  Oceania=2 [20.0%]  ORF3a protein, V256I</title>
	<circle cx="299.194270415463" cy="941.698113576538" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-13  ATTA21993A  Europe=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="426.364164806765" cy="963.475788905532" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-14  AATA6509A  Europe=3 [0.3%]  orf1ab polyprotein, N2082S</title>
	<circle cx="883.722497596369" cy="1097.23520999371" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-14  ATTA21993A  Europe=5 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="430.609909955933" cy="950.010005658273" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-14  ATTA22190A  Europe=5 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="424.845044303313" cy="948.136887261601" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-14  GTTA26158G  Europe=4 [0.4%]  ORF3a protein, V256D</title>
	<circle cx="308.728359483031" cy="910.408289302222" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-15  AGTT11282A  Europe=2 [0.1%]  orf1ab polyprotein, S3673M</title>
	<circle cx="746.703848418063" cy="1043.9176180124" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-15  ATTA22190A  Europe=4 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="429.358721567683" cy="934.646927894904" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-15  C28932CTTTTG  Europe=2 [0.1%]  nucleocapsid phosphoprotein, L221F</title>
	<circle cx="233.214529669511" cy="867.109066437976" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-15  TTGCTG28934T  Europe=2 [0.1%]  nucleocapsid phosphoprotein, L221S</title>
	<circle cx="233.156343911013" cy="867.089031474625" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-16  ATTA22190A  Europe=2 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="434.107143630833" cy="921.237797644503" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-16  GTTA26158G  Europe=2 [0.3%]  ORF3a protein, V256D</title>
	<circle cx="319.377903037649" cy="879.479769068619" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-16  TCAT27296T  Europe=2 [0.3%]  ORF6 protein, I33N</title>
	<circle cx="286.474204500592" cy="867.503802203861" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-16  GGTT28089G  Asia=3 [11.1%]  ORF8 protein, G66A</title>
	<circle cx="263.545704553415" cy="859.158510706715" r="1.90848501887865" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-17  CA28253C  North America=6 [7.1%]  ORF8 protein, I121S</title>
	<circle cx="264.925844820403" cy="841.058661735427" r="3.11260500153457" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-18  A11085ATTT  Asia=2 [6.2%]  orf1ab polyprotein, E3608F</title>
	<circle cx="761.113956349063" cy="1022.67852821199" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-19  ATTA22190A  Europe=3 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="449.746059596871" cy="881.53609653685" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-20  ATTA22190A  Europe=4 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="455.418288384774" cy="868.490863432773" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-21  TATG517T  Europe=2 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1065.69912915789" cy="1137.37447542944" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-21  ATTA21993A  Europe=2 [0.1%]  surface glycoprotein, Y145H</title>
	<circle cx="466.810943484074" cy="858.108328071185" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-21  ATTA22190A  Europe=9 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="461.317323974959" cy="855.546611223096" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-21  GTTA26158G  Europe=3 [0.2%]  ORF3a protein, V256D</title>
	<circle cx="350.664114776146" cy="803.948172374262" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-21  TCAT27296T  Europe=2 [0.1%]  ORF6 protein, I33N</title>
	<circle cx="318.92939903314" cy="789.150031393926" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-22  TATG517T  Europe=2 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1066.81254993918" cy="1135.04014021735" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-22  ATTA22190A  Europe=4 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="467.441369464042" cy="842.707282852435" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-22  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="357.70553021127" cy="789.185537915233" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-23  TTAT516T  Europe=3 [0.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1067.99395649332" cy="1132.73956134628" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-23  ATTA22190A  Europe=3 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="473.788559408441" cy="829.976789304589" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-24  ATTA21993A  Europe=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="485.708981186249" cy="820.204728345642" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-25  ATTA22190A  Europe=3 [0.7%]  surface glycoprotein, I210N</title>
	<circle cx="487.144571617986" cy="804.857783670609" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-26  ATTA22190A  Europe=18 [0.6%]  surface glycoprotein, I210N</title>
	<circle cx="494.149325512431" cy="792.476923076923" r="5.02109002041322" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-27  ATTA22190A  Europe=3 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="501.369088360054" cy="780.220197960233" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-27  AATT27578A  Europe=2 [0.2%]  ORF7a protein, Q62H</title>
	<circle cx="359.263937092885" cy="694.834808802837" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-28  ATTA22190A  Europe=3 [0.8%]  surface glycoprotein, I210N</title>
	<circle cx="508.801660951152" cy="768.091341837743" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-29  TATT20424T  Europe=4 [0.4%]  orf1ab polyprotein, I6721P</title>
	<circle cx="562.016847651855" cy="785.68889653303" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-29  ATTA21993A  Europe=3 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="521.528413156274" cy="759.39539973492" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-29  ATTA22190A  Europe=4 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="516.444779252113" cy="756.094049276521" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-29  C28994CGGC  Europe=4 [0.4%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="340.865870196708" cy="642.071772530606" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-30  ATTA22190A  Europe=10 [0.9%]  surface glycoprotein, I210N</title>
	<circle cx="524.296115095062" cy="744.231974768104" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-30  T25704TCCC  Europe=4 [0.4%]  ORF3a protein, F105P</title>
	<circle cx="434.658021865572" cy="683.770317451298" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-10-31  ATTA22190A  Europe=2 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="532.353276887043" cy="732.508731615296" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-01  ATTA22190A  Europe=14 [0.9%]  surface glycoprotein, I210N</title>
	<circle cx="540.613810338524" cy="720.927890831529" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-01  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="441.839058532992" cy="649.163832951635" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-02  ATTA9859A  Europe=2 [0.1%]  orf1ab polyprotein, L3199P</title>
	<circle cx="852.08979842309" cy="937.83085852964" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-02  ATTA21993A  Europe=3 [0.1%]  surface glycoprotein, Y145H</title>
	<circle cx="553.916159071895" cy="713.140904962657" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-02  ATTA22190A  Europe=12 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="549.075199210993" cy="709.492980053089" r="4.3167249841905" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-02  GTTA26158G  Europe=5 [0.2%]  ORF3a protein, V256D</title>
	<circle cx="451.567946784295" cy="636.015995072556" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-02  TCAT27296T  Europe=2 [0.1%]  ORF6 protein, I33N</title>
	<circle cx="423.603417232486" cy="614.94321056957" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-03  GGTT28089G  Asia=2 [16.7%]  ORF8 protein, G66A</title>
	<circle cx="414.70485268263" cy="586.460188835464" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-04  ATTA22190A  Europe=10 [0.8%]  surface glycoprotein, I210N</title>
	<circle cx="566.590173137425" cy="687.074835737872" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-04  C28994CGGC  Europe=2 [0.2%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="403.891677083479" cy="555.324191408546" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-05  ATTA22190A  Europe=3 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="575.638422960658" cy="676.098430985023" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-05  GTTA26158G  Europe=2 [0.2%]  ORF3a protein, V256D</title>
	<circle cx="482.110289105393" cy="597.619008362371" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-05  C28994CGGC  Europe=2 [0.2%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="415.264072468919" cy="541.528372637109" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-06  GGTT28089G  Asia=2 [11.8%]  ORF8 protein, G66A</title>
	<circle cx="447.891265099842" cy="546.201851355552" r="1.20411998265592" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-07  ATTA21993A  Europe=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="598.807269186103" cy="658.683633772705" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-08  ATTA22190A  Europe=19 [1.2%]  surface glycoprotein, I210N</title>
	<circle cx="603.912978394147" cy="644.139859701676" r="5.11501440381132" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  TATG517T  Europe=3 [0.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1093.40490835597" cy="1097.06231654983" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  ATTA9859A  Europe=2 [0.1%]  orf1ab polyprotein, L3199P</title>
	<circle cx="886.633449440166" cy="897.385439724354" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  A11085ATTT  Europe=2 [0.1%]  orf1ab polyprotein, E3608F</title>
	<circle cx="859.49773881816" cy="871.18078858027" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  ATTA21993A  Europe=4 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="618.06516829219" cy="638.032065350524" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  ATTA22190A  Europe=4 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="613.704862425522" cy="633.821366920357" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="525.879006187252" cy="549.00892341324" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-09  GTTA26158G  Europe=2 [0.1%] North America=2 [0.9%]  ORF3a protein, V256D</title>
	<circle cx="525.879006187252" cy="549.00892341324" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-10  G25767GAAT  North America=2 [1.0%]  ORF3a protein, R126N</title>
	<circle cx="545.850077441393" cy="545.850077441393" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-11  TATG517T  Europe=2 [0.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1097.06231654983" cy="1093.40490835597" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-11  ATTA22190A  Europe=14 [1.1%]  surface glycoprotein, I210N</title>
	<circle cx="633.821366920358" cy="613.704862425522" r="4.58451214271295" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-12  AATG3545A  North America=3 [2.1%]  orf1ab polyprotein, N1094R</title>
	<circle cx="1035.3970727283" cy="1023.48497121536" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-12  ATTA21993A  Europe=3 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="648.273818991901" cy="608.346106985501" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-12  ATTA22190A  Europe=6 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="644.139859701676" cy="603.912978394147" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-12  TGTT26157T  Europe=2 [0.1%]  ORF3a protein, V256N</title>
	<circle cx="560.894090644201" cy="514.642820414971" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-12  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="560.873106079276" cy="514.620317224151" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-13  G11083GTTT  Europe=2 [0.1%]  orf1ab polyprotein, Y3607F</title>
	<circle cx="883.305631168863" cy="848.275270600207" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-13  A11085ATTT  Europe=2 [0.1%]  orf1ab polyprotein, E3608F</title>
	<circle cx="883.264453900779" cy="848.229538610947" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-13  ATTA22190A  Europe=6 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="654.627672866468" cy="594.302668243979" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-14  A11085ATTT  Europe=2 [0.1%]  orf1ab polyprotein, E3608F</title>
	<circle cx="889.451935323386" cy="842.755317472396" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-14  ATTA21993A  Europe=4 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="669.25833876251" cy="589.451560516396" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-14  ATTA22190A  Europe=10 [0.6%]  surface glycoprotein, I210N</title>
	<circle cx="665.281611725245" cy="584.876859368584" r="4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-14  GTTA26158G  Europe=7 [0.4%]  ORF3a protein, V256D</title>
	<circle cx="585.181850893419" cy="492.732625081693" r="3.38039216005703" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-14  C28994CGGC  Europe=2 [0.1%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="527.933130702124" cy="426.875506019792" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-15  ATTA21993A  Europe=2 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="679.994712803739" cy="580.281830815872" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-15  ATTA22190A  Europe=2 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="676.098430985023" cy="575.638422960658" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-15  C28994CGGC  Europe=4 [0.5%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="541.528372637109" cy="415.264072468919" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  TTAT516T  Europe=6 [0.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1106.76376360292" cy="1084.86283678722" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  ATAA3951A  North America=2 [0.6%]  orf1ab polyprotein, D1229E</title>
	<circle cx="1040.24943919504" cy="1002.72448670708" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  AATA6509A  Europe=12 [0.9%]  orf1ab polyprotein, N2082S</title>
	<circle cx="990.717083493334" cy="941.557121494556" r="4.3167249841905" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  ATTA9859A  Europe=2 [0.1%]  orf1ab polyprotein, L3199P</title>
	<circle cx="925.848673954351" cy="861.451307005914" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  TT11083T  Europe=12 [0.9%]  orf1ab polyprotein, L3606F</title>
	<circle cx="902.147499842197" cy="832.182794488273" r="4.3167249841905" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  ATTA22190A  Europe=4 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="687.074835737872" cy="566.590173137425" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-16  TT29589T  Europe=9 [0.7%]  ORF10 protein, F11L</title>
	<circle cx="543.80278732625" cy="389.663927942959" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-17  ATTA21993A  Europe=5 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="701.939338176548" cy="562.511423574525" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-17  ATTA22190A  Europe=5 [0.7%]  surface glycoprotein, I210N</title>
	<circle cx="698.207482464574" cy="557.734866083432" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-17  C28994CGGC  Europe=2 [0.3%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="569.316384676396" cy="392.761784005274" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-18  ATTA21993A  Europe=4 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="713.140904962657" cy="553.916159071895" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-18  ATTA22190A  Europe=9 [0.6%]  surface glycoprotein, I210N</title>
	<circle cx="709.492980053089" cy="549.075199210993" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-18  T25704TCCC  Europe=4 [0.3%]  ORF3a protein, F105P</title>
	<circle cx="644.422888011357" cy="462.724270524648" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-19  ATTA21993A  Europe=2 [0.6%]  surface glycoprotein, Y145H</title>
	<circle cx="724.490773745425" cy="545.517697965966" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-20  ATTA21993A  Europe=2 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="735.985487244871" cy="537.318598509349" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-20  ATTA22190A  Oceania=2 [33.3%]  surface glycoprotein, I210N</title>
	<circle cx="732.508731615297" cy="532.353276887043" r="1.20411998265592" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-21  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="935.303888400186" cy="807.571876425023" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-21  ATTA21993A  Europe=2 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="747.621544059911" cy="529.321358227165" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-21  ATTA22190A  Europe=3 [0.6%]  surface glycoprotein, I210N</title>
	<circle cx="744.231974768104" cy="524.296115095062" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-23  ATTA21993A  Europe=4 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="771.303467839402" cy="513.942137103238" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-23  ATTA22190A  Europe=3 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="768.091341837743" cy="508.801660951152" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-23  TGTT26157T  Europe=2 [0.1%]  ORF3a protein, V256N</title>
	<circle cx="703.408581185031" cy="405.28760564492" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-24  A26086ATTC  South America=2 [9.1%]  ORF3a protein, Y233L</title>
	<circle cx="718.479018272554" cy="398.614509789733" r="1.20411998265592" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-24  TT27206T  South America=2 [9.1%]  ORF6 protein, H3I</title>
	<circle cx="700.730013844884" cy="369.075205888614" r="1.20411998265592" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-27  GTAG425G  North America=3 [1.8%]  orf1ab polyprotein, V54E</title>
	<circle cx="1131.76050268921" cy="1071.66017142567" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-27  ATTA22190A  Europe=2 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="817.359008411217" cy="480.356960392612" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-30  GTAG425G  North America=3 [0.7%]  orf1ab polyprotein, V54E</title>
	<circle cx="1138.57081020114" cy="1068.26467735504" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-30  ATTA21993A  Europe=7 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="858.108328071185" cy="466.810943484074" r="3.38039216005703" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-11-30  ATTA22190A  Europe=4 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="855.546611223096" cy="461.317323974959" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-01  ATGA1431A  Europe=2 [0.5%]  orf1ab polyprotein, N389K</title>
	<circle cx="1128.28920108233" cy="1038.93490854486" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-01  ATAA3951A  North America=2 [1.1%]  orf1ab polyprotein, D1229E</title>
	<circle cx="1096.75146752691" cy="968.099999213801" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-01  AATT27578A  Europe=3 [0.7%]  ORF7a protein, Q62H</title>
	<circle cx="801.060185497622" cy="303.966506053133" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-03  GTTA26158G  Europe=2 [0.4%]  ORF3a protein, V256D</title>
	<circle cx="848.941753364048" cy="331.10034896798" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-04  ATTA21993A  North America=2 [1.1%]  surface glycoprotein, Y145H</title>
	<circle cx="910.085842170922" cy="444.747797739556" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-04  GTTA26158G  Europe=2 [0.6%]  ORF3a protein, V256D</title>
	<circle cx="864.159611098424" cy="325.105875389992" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-06  TTAT516T  Europe=2 [0.4%]  orf1ab polyprotein, M85V</title>
	<circle cx="1151.76582573196" cy="1059.91778641506" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-06  A11085ATTT  Europe=2 [0.4%]  orf1ab polyprotein, E3608F</title>
	<circle cx="1045.8910619025" cy="752.435145630157" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-06  ATTA22190A  Europe=3 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="934.646927894904" cy="429.358721567683" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-07  TATG517T  Europe=3 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1154.20843554124" cy="1059.06805592377" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-07  TT11083T  Europe=2 [0.1%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1053.74463361614" cy="749.87226665686" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-07  ATTA21993A  Europe=13 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="950.010005658273" cy="430.609909955933" r="4.45577340922735" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-07  ATTA22190A  Europe=6 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="948.136887261601" cy="424.845044303313" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-07  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="910.408289302222" cy="308.728359483031" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-08  AATT27578A  Europe=5 [1.0%]  ORF7a protein, Q62H</title>
	<circle cx="913.232835955487" cy="262.026870589733" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-09  AATT27578A  Europe=2 [0.3%]  ORF7a protein, Q62H</title>
	<circle cx="929.646400265277" cy="257.164951340745" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-10  ATTA21993A  Europe=2 [0.2%]  surface glycoprotein, Y145H</title>
	<circle cx="990.619374343524" cy="418.580866929471" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-10  TGTT26157T  Europe=2 [0.2%]  ORF3a protein, V256N</title>
	<circle cx="957.458681918696" cy="294.82347798585" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-10  GTTA26158G  Europe=2 [0.2%]  ORF3a protein, V256D</title>
	<circle cx="957.45071825577" cy="294.793757191195" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-10  AATT27578A  Europe=5 [0.5%]  ORF7a protein, Q62H</title>
	<circle cx="946.142316900521" cy="252.590228781027" r="2.79588001734407" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-11  ATTA21993A  Europe=4 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1004.28890833519" cy="415.045685069277" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-11  AATT27578A  Europe=2 [0.2%]  ORF7a protein, Q62H</title>
	<circle cx="962.715561045212" cy="248.304096415387" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-12  ATTA21993A  Europe=3 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1018.01805782126" cy="411.749607897434" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-13  ATTA21993A  Europe=3 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1031.80264076983" cy="408.693639430978" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-13  ATTA22190A  Europe=3 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="1030.54237605933" cy="402.764560128068" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-13  C28994CGGC  Europe=4 [0.7%]  nucleocapsid phosphoprotein, Q241R</title>
	<circle cx="987.015263926287" cy="197.985597808289" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-14  TT11083T  Europe=3 [0.1%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1109.69157024978" cy="735.403405052555" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-14  ATTA21993A  Europe=9 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1045.63845826338" cy="405.878710547508" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-14  ATTA21993A  Europe=9 [0.3%] North America=2 [1.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1045.63845826338" cy="405.878710547508" r="1.20411998265592" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-14  ATTA22190A  Europe=8 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="1044.4818621991" cy="399.928539620149" r="3.61235994796777" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-14  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="1021.18555162513" cy="280.079411499523" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-14  TT29589T  Europe=6 [0.2%]  ORF10 protein, F11L</title>
	<circle cx="1001.04199275937" cy="176.449784840787" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-15  ATTA21993A  Europe=3 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1059.52129577788" cy="403.305678701632" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-15  ATTA22190A  Europe=2 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="1058.46872067017" cy="397.336228629527" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-15  GTTA26158G  Europe=2 [0.3%]  ORF3a protein, V256D</title>
	<circle cx="1037.26761393226" cy="277.09877743099" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-16  ATTA21993A  Europe=3 [0.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1073.44692446653" cy="400.975327663773" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-16  GTTA26158G  Europe=3 [0.4%]  ORF3a protein, V256D</title>
	<circle cx="1053.39924610061" cy="274.399268015197" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-17  TTAT516T  Europe=2 [0.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1179.38096981161" cy="1053.28797689259" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-17  ATTA21993A  North America=3 [2.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1087.41110244794" cy="398.888367281435" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-17  ATTA22190A  Europe=3 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="1086.56749934366" cy="392.885819295524" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-17  GTTA26158G  Europe=2 [0.2%]  ORF3a protein, V256D</title>
	<circle cx="1069.57553427875" cy="271.981705548861" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-18  ATTA21993A  Europe=2 [0.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1101.40957609821" cy="397.045433262965" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-18  ATTA22190A  Europe=3 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="1100.67086038588" cy="391.029076589939" r="1.90848501887865" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-18  GTTA26158G  Europe=2 [0.3%]  ORF3a protein, V256D</title>
	<circle cx="1085.7915510126" cy="269.846826444931" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-19  ATTA21993A  Europe=4 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1115.43808134667" cy="395.447086983919" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-20  ATTA21993A  Europe=9 [1.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1129.49234497473" cy="394.093815316056" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  TTAT516T  Europe=2 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1189.66531012068" cy="1052.2070491692" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  TT11083T  Europe=6 [0.2%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1166.98479756517" cy="727.860608581643" r="3.11260500153457" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  ATTA21993A  Europe=26 [0.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1143.56808591752" cy="392.986030479037" r="5.65989339188327" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  ATTA22190A  Europe=32 [1.1%]  surface glycoprotein, I210N</title>
	<circle cx="1143.14525436898" cy="386.939257620539" r="6.02059991327962" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  G25767GAAT  North America=3 [1.8%]  ORF3a protein, R126N</title>
	<circle cx="1135.46774955105" cy="277.145823535019" r="1.90848501887865" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  GTTA26158G  Europe=9 [0.3%]  ORF3a protein, V256D</title>
	<circle cx="1134.62852551308" cy="265.144360653432" r="3.8169700377573" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  TGT27462T  Europe=2 [0.1%]  ORF7a protein, V24*</title>
	<circle cx="1131.82968115116" cy="225.119021529161" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-21  TT29589T  Europe=4 [0.1%]  ORF10 protein, F11L</title>
	<circle cx="1127.26438823874" cy="159.832291224464" r="2.40823996531185" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-22  ATTA21993A  Europe=8 [1.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1157.66101656802" cy="392.124069914854" r="3.61235994796777" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-22  GTTA26158G  Europe=2 [0.4%]  ORF3a protein, V256D</title>
	<circle cx="1150.95396248334" cy="264.145854153229" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-23  C21762CTTAT  Europe=8 [1.9%]  surface glycoprotein, I68Y</title>
	<circle cx="1172.01489896727" cy="398.611558678626" r="3.61235994796777" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-23  ATTA21993A  Europe=2 [0.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1171.76684408301" cy="391.508196185044" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-23  T24910TCACA  Europe=2 [0.5%]  surface glycoprotein, T1117H</title>
	<circle cx="1168.63448002513" cy="301.809025649207" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-23  AGACA24913A  Europe=2 [0.5%]  surface glycoprotein, D1118T</title>
	<circle cx="1168.63125853312" cy="301.716774188252" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<g>
	<title>2020-12-24  ATTA21993A  Europe=2 [1.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1185.8812716908" cy="391.138596890713" r="1.20411998265592" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.15;"/>
</g>
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 6 continents</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Genomes/year≥10  Genomes/day≥2</text>
<text font-size="1.8em" x="1880" y="230" fill="white">51 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-01-19</text>
</svg>
